Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Phagelux to Develop Phage-Based Skin Care Antibacterials with J&J

publication date: Apr 12, 2017
Phagelux will collaborate with Johnson and Johnson Consumer to develop phage-based antibacterial skin care products. Phagelux, headquartered in Shanghai, but with labs in Nanjing and Montreal, is dedicated to developing novel phage and lysin antibacterial products. Bacteriophages are viruses that infect bacteria and destroy them, an alternative mechanism to normal antibiotics. Phagelux's work with J&J will be aimed at "one or more" bacteriophage skin care products that will address either difficult-to-address or antibiotic-resistant bacteria. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital